Financial News
FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants
January 26, 2023 at 23:20 PM EST
Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
